Institution
Feinstein Institute for Medical Research
- 2running trials
- 5closed trials
- 9,190publications (OpenAlex)
Running trials
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease1 recruiting
- Schizophrenia1 recruiting
Closed trials
Terminated
Terminated
COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)
Completed
Personalized Integrated Chronotherapy for Perinatal Depression
Completed
Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE)
Registry name variants (3)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Feinstein Institute for Medical Research
Manhasset, New York 11030
3 trials
The Feinstein Institute for Medical Research
Manhasset, New York 11030
3 trials
Contact: Jeremy Koppel, Site 0049
NCT03900273Development of Novel Measures for Alzheimer's Disease Prevention Trials
NCT02633163Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE)
Feinstein Institute for Medical Research
Glen Oaks, New York 11004
2 trials
NCT06969755Biomarkers to Enhance Early Schizophrenia Treatment
Contact: Taylor Marzouk Coordinator
NCT04364646Personalized Integrated Chronotherapy for Perinatal Depression
Conditions
Diseases this institution publishes on or runs trials for.
- Schizophrenia62 works · 1 trial
- Lupus (SLE)23 works · 2 trials
Institution data: ROR 05dnene97 (CC0-1.0)Updated 15 Nov 2026